Should ocd be classified as an anxiety disorder in DSM-V?

Depression and Anxiety

Volumn 27, Issue 6, 2010, Pages 495-506

  Stein, Dan J ^a   Fineberg, Naomi A ^b,c   Bienvenu, O Joseph ^d   Denys, Damiaan ^e   Lochner, Christine ^f   Nestadt, Gerald ^d   Leckman, James F ^g   Rauch, Scott L ^h   Phillips, Katharine A ⁱ  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ BROWN UNIVERSITY   (United States)

Author keywords

Anxiety disorder; Classification; Nosology; Obsessive compulsive disorder; Obsessive compulsive spectrum disorder

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUSPIRONE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; BEHAVIOR THERAPY; COGNITION; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE COURSE; EMOTION; ENVIRONMENTAL FACTOR; HUMAN; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SYMPTOM; TEMPERAMENT; TREATMENT RESPONSE;

ANXIETY DISORDERS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MOOD DISORDERS; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER;

EID: 77953516844     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20699     Document Type: Review

References (117)

1. http://www.psych.org/MainMenu/Research/DSMIV/DSMV/DSMRevisionActivities/ ConferenceSummaries/ObsessiveCompulsiveSpectrumDisordersConference.aspx. 2009.
2. Hollander E, Kim S, Zohar J. OCDs in the forthcoming DSM-V. CNS Spectrums 2007;12:320-323.
3. Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety 2008;25:317-329.
4. Storch EA, Abramowitz J, Goodman WK. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety 2008;25:336-347.
5. Stein DJ. Is disorder x in category or spectrum y? General considerations and application to the relationship between obsessive-compulsive disorder and anxiety disorders. Depress Anxiety 2008;25:330-335.
6. Kendler KS. Towards a scientific nosology: strengths and limitations. Arch Gen Psychiatry 1990;47:969-973.
7. Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 2007;8:725-732.
8. Langlois F, Freeston MH, Ladouceur R. Differences and similarities between obsessive intrusive thoughts and worry in a non-clinical population: study 1. Behav Res Ther 2000;38: 157-173. (Pubitemid 29512183)
9. Nutt D, Malizia A. Anxiety and OCD - the chicken or the egg? J Psychopharmacol 2006;20:729-731.
10. Parkinson L, Rachman S. Are intrusive thoughts subject to habituation. Behav Res Ther 1980;18:409-418.
11. Dias-Ferreira E, Sousa JC, Melo I, et al. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009;325:621-625.
12. Ladouceur R, Freeston MH, Rheaume J, et al. Strategies used with intrusive thoughts: a comparison of OCD patients with anxious and community controls. J Abnorm Psychol 2000;109: 179-187.
13. Leckman JF, Mayes LC. Understanding developmental psychopathology: how useful are evolutionary accounts. J Am Acad Child Adolesc Psychiatry 1998;37:1011-1021.
14. Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007;6:168-176. (Pubitemid 350047829)
15. Rosenbaum JF, Biederman J, Faraone SV, et al. Behavioral inhibition in childhood: a risk factor for anxiety disorders. Biol Psychiatry 1997;42:145S.
16. Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004; 110:4-13.
17. Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuro-Psychopharmacol Biol Psychiatry 2006;30:338-352.
18. Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:53-63.
19. Nestadt G, Addington A, Samuels J, et al. The identification of OCD-related subgroups based on comorbidity. Biol Psychiatry 2003;53:914-920.
20. Nestadt G, Di CZ, Riddle MA, et al. Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med 2009;39:1491-1501.
21. Richter MA, Summerfeldt LJ, Antony MM, et al. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety 2003;18: 118-127.
22. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry 1999;56:921-926.
23. Slade TIM, DAVI Watson. The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Psychol Med 2006;36:1593-1600.
24. Cox BJ, Clara IP, Hills AL, et al. Obsessive-compulsive disorder and the underlying structure of anxiety disorders in a nationally representative sample: confirmatory factor analytic findings from the German Health Survey. J Anxiety Disord 2010;24:30-33.
25. Wittchen HU, Beesdo-Baum K, Gloster AT, Höfler M, Klotsche J, Lieb R, Beauducel A, Bühner M, Kessler RC. The structure of mental disorders re-examined: is it developmentally stable and robust against additions? Int J Methods Psychiatr Res 2009;18:189-203.
26. Shin LM, Liberzon I. The Neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010;35:169-191.
27. Rauch SL, Drevets WC. Neuroimaging and neuroanatomy of stress-induced and fear circuitry disorders. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA, editors. Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Association
28. Phelps EA, Delgado MR, Nearing KI, et al. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004; 43:897-905.
29. Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci 2006;26:9503-9511.
30. Milad MR, Wright CI, Orr SP, et al. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 2007;62:446-454.
31. Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol Psychiatry 2006; 60:76-382.
32. Simon D, Kaufmann C, Müsch K, Kischkel E, Kathmann N. Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. Psychophysiology 2010; in press.
33. Feusner JD, Townsend J, Bystritsky A, et al. Visual information processing of faces in body dysmorphic disorder. Arch Gen Psychiatry 2007;64:1417-1426.
34. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001;50:651-658.
35. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164:1476-1488.
36. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry 2006;60:383-387.
37. Warwick JM, Carey P, van der Linden G, et al. A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder. Metab Brain Dis 2006; 21:241-245.
38. van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009; 132:853-868.
39. Shapira NA, Liu Y, He AG, et al. Brain activation by disgustinducing pictures in obsessive-compulsive disorder. Biol Psychiatry 2003;54:751-756.
40. Stein DJ, Arya M, Pietrini P, et al. Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder: a positron emission tomography study. Metab Brain Dis 2006;21:267-277.
41. Fitzgerald KD, Welsh RC, Gehring WJ, et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 2005;57:287-294.
42. Rauch SL, Wedig MM, Wright CI, et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007;61:330-336.
43. Rauch SL. Baxter Jr LR. Neuroimaging in obsessive-compulsive disorder and related disorders. In: Jenicke MA, Baer L, Minichiello WE, editors. Obsessive-Compulsive Disorders: Practical Management. 3rd ed. St. Louis, MI: Mosby; 1998.
44. Greenberg BD, Suzanne SLR, Haber SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010;35:317-336.
45. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008;32:525-549.
46. Rotge JY, Guehl D, Dilharreguy B, et al. Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci 2008;33:405-412.
47. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res Neuroimaging 2004;132:69-79.
48. Cannistraro PA, Wright CI, Wedig MM, et al. Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry 2004;56:916-920.
49. Feusner JD, Moody T, Hembacher E, et al. Abnormalities of visual processing and fronto-striatal systems in body dysmorphic disorder. Arch Gen Psychiatry 2010;67:197-205.
50. Frey KA, Albin RL. Neuroimaging of Tourette syndrome. J Child Neurol 2006;21:672-677.
51. Rauch SL, Phillips KA, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res Neuroimaging 2003;122:13-19.
52. Stein DJ. Psychobiology of anxiety disorders and obsessive-compulsive spectrum disorders. CNS Spectrums 2008;13: 23-28.
53. Bohlhalter S, Goldfine A, Matteson S, et al. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006;129:2029-2037.
54. Hampson M, Tokoglu F, King RA, et al. Brain areas coactivating with motor cortex during chronic motor tics and intentional movements. Biol Psychiatry 2009;65:594-599.
55. Saxena S, Brody AL, Maidment KM, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004;161:1038-1048.
56. Rauch SL, Shin LM, Whalen PJ, Pitman RK. Neuroimaging and the neuroanatomy of posttraumatic stress disorder. CNS Spectrums 1998;3:31-41.
57. Mataix-Cols D, Wooderson S, Lawrence N, et al. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:564-576.
58. Hettema JM, Neale MC, Kendler KS. A review and metaanalysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
59. Black DW, Noyes R, Goldstein RB, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49: 362-368.
60. Nestadt G, Samuels J, Riddle MA, et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med 2001;31:481-487.
61. Carter AS, Pollock RA, Suvak MK, et al. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Depress Anxiety 2004;20:165-174.
62. Fyer AJ, Lipsitz JD, Mannuzza S, et al. A direct interview family study of obsessive-compulsive disorder. I. Psychol Med 2005;35:1611-1621.
63. Bolton D, Rijsdijk F, O'Connor TG, et al. Obsessive-compulsive disorder, tics and anxiety in 6-year-old twins. Psychol Med 2007;37:39-48.
64. Tambs K, Czajkowsky N, Roysamb E, et al. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. Br J Psychiatry 2009;195: 301-307.
65. Noyes R, Crowe RR, Harris EL, et al. Relationship between panic disorder and agoraphobia - a family study. Arch Gen Psychiatry 1986;43:227-232.
66. Noyes R, Clarkson C, Crowe RR, et al. A family study of generalized anxiety disorder. Am J Psychiatry 1987;144: 1019-1024.
67. Mendlewicz J, Papadimitriou G, Wilmotte J. Family study of panic disorder - comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatr Genet 1993;3: 73-78.
68. Goldstein RB, Weissman MM, Adams PB, et al. Psychiatric-disorders in relatives of probands with panic disorder and/or major depression. Arch Gen Psychiatry 1994;51: 383-394.
69. Biederman J, Petty C, Faraone SV, et al. Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord 2006;94:191-197. (Pubitemid 44093040)
70. Samuels J, Nestadt G, Bienvenu OJ, et al. Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry 2000;177:457-462.
71. Ettelt S, Grabe HJ, Ruhrmann S, et al. Harm avoidance in subjects with obsessive-compulsive disorder and their families. J Affect Disord 2008;107:265-269.
72. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10: 1089-1093.
73. Hemmings SMJ, Kinnear CJ, Van Der Merwe L, et al. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry 2008;9:126-134.
74. Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 2008;33: 312-319.
75. Binder EB, Bradley RG, Liu W, et al. Association of FKBP5 Polymorphisms and Childhood Abuse With Risk of Posttraumatic Stress Disorder Symptoms in Adults. JAMA 2008;299: 1291-1305.
76. Fyer AJ, Hamilton SP, Durner M, et al. A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol Psychiatry 2006;60.
77. Shugart YY, Samuels J, Willour VL, et al. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 2006;11:763-770.
78. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320.
79. Lochner C, du Toit PL, Zungu-Dirwayi N, et al. Childhood trauma in obsessive-compulsive disorder, trichotillomania, and controls. Depress Anxiety 2002;15:66-68.
80. Didie ER, Tortolani CC, Pope CG, et al. Childhood abuse and neglect in body dysmorphic disorder. Child Abuse Negl 2006; 30:1105-1115.
81. Grabe HJ, Ruhrmann S, Spitzer C, et al. Obsessive-compulsive disorder and posttraumatic stress disorder. Psychopathology 2008;41:129-134.
82. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000;140:577-583.
83. Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE, What is an anxiety disorder? Depress Anxiety 2009;26:1066-1068.
84. Coles ME, Schofield CA, Pietrefesa AS. Behavioral inhibition and obsessive-compulsive disorder. J Anxiety Disord 2006;20: 1118-1132.
85. Chik HM, Whittal ML, O'Neill ML. Perfectionism and treatment outcome in obsessive-compulsive disorder. Cogn Ther Res 2008;32:676-688.
86. Lee JC, Prado HS, Diniz JB, et al. Perfectionism and sensory phenomena: phenotypic components of obsessive-compulsive disorder. Compr Psychiatry 2009;50:431-436.
87. Buhlmann U, Etcoff NL, Wilhelm S. Facial attractiveness ratings and perfectionism in body dysmorphic disorder and obsessive-compulsive disorder. J Anxiety Disord 2008;22: 540-547. (Pubitemid 351375365)
88. Sassaroli S, Lauro LJR, Ruggiero GM, et al. Perfectionism in depression, obsessive-compulsive disorder and eating disorders. Behav Res Ther 2008;46:757-765.
89. Hur YM. Genetic and environmental covariations among obsessive-compulsive symptoms, neuroticism, and extraversion in South Korean adolescent and young adult twins. Twin Res Hum Genet 2009;12:142-149.
90. Lahey BB. Public health significance of neuroticism. Am Psychol 2009;64:241-256.
91. Baer L, Jenike MA. Personality-disorders in obsessive-compulsive disorder. Psychiatr Clin North Am 1992;15:803-812.
92. Roy AK, Vasa RA, Bruck M, et al. Attention bias toward threat in pediatric anxiety disorders. J Am Acad Child Adolesc Psychiatry 2008;47:1189-1196.
93. Reeb-Sutherland BC, Helfinstein SM, Degnan KA, et al. Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J Am Acad Child Adolesc Psychiatry 2009;48:610-617.
94. Shafran R, Rachman S. Thought-action fusion: a review. J Behav Ther Exp Psychiatry 2004;35:87-107.
95. Chamberlain SR, Fineberg NA, Blackwell AD, et al. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 2006;163: 1282-1284.
96. Menzies L, Achard S, Chamberlain SR, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130:3223-3236.
97. Oosterlaan J, Logan GD, Sergeant JA. Response inhibition in AD/HD, CD, comorbid AD/HD1CD, anxious, and control children: a meta-analysis of studies with the stop task. J Child Psychol Psychiatry 1998;39:411-425.
98. Casada JH, Roache JD. Dissociation of physiology and behavior in PTSD. Int J Psychophysiol 2006;62:243-248.
99. Castaneda AE, Tuuio-Henriksson A, Marttunen M, et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008; 106:1-27.
100. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998;55:415-423.
101. Boldrini M, Del Pace L, Placidi GPA, et al. Selective cognitive deficits in obsessive-compulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr Scand 2005;111: 150-158.
102. van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 2005;62:922-933.
103. Airaksinen E, Larsson M, Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 2005; 39:207-214.
104. Thorpe SJ, Salkovskis PM. Studies on the role of disgust in the acquisition and maintenance of specific phobias. Behav Res Ther 1998;36:877-893.
105. Stein DJ, Liu Y, Shapira NA, et al. The psychobiology of obsessive-compulsive disorder: how important is the role of disgust? Curr Psychiatry Rep 2001;3:281-287.
106. Craig K, Chamberlain S. The neuropsychology of anxiety disorders. In: Stein DJ, Hollander E, Rothbaum BO, editors. Textbook of Anxiety Disorders. 2nd ed. Washington, DC: American Psychiatric Publishing; 2010.
107. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005;19:567-596.
108. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 2008;9:248-312.
109. Stein DJ, Ipser JC, Baldwin DS, et al. Treatment of obsessive-compulsive disorder. CNS Spectrums 2007;12:28-35.
110. Stein DJ, Ipser JC, van Balkom AJ. Pharmacotherapy for social anxiety disorder. Cochrane Database Syst Rev 2004; CD001206.
111. Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 2005;8:107-129.
112. Stein DJ, Denys D, Gloster AT, et al. Obsessive-compulsive disorder: diagnostic and Treatment Issues. Psychiatr Clin North Am 2009;32:665-666.
113. Geffken GR, Storch EA, Gelfand KM, et al. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv 2004;42:44-51.
114. Arch JJ, Craske MG. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am 2009;32:525-552.
115. Himle MB, Woods DW, Piacentini JC, et al. Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006;21:719-725.
116. Bloch MH, Landeros-Weisenberger A, Dombrowski P, et al. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry 2007;62: 839-846.
117. Mataix-Cols D, Pertusa A, Leckman JF. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 2007;164:1313-1314.